Selected article for: "aberrant type and adaptive immunity"

Author: Ke, Hanzhong; Yoo, Dongwan
Title: The viral innate immune antagonism and an alternative vaccine design for PRRS virus
  • Cord-id: rc3ayjf6
  • Document date: 2017_3_18
  • ID: rc3ayjf6
    Snippet: Porcine reproductive and respiratory syndrome (PRRS) remains one of the most economically significant diseases in the swine industry worldwide. The current vaccines are less satisfactory to confer protections from heterologous infections and long-term persistence, and the need for better vaccines are urgent. The immunological hallmarks in PRRSV-infected pigs include the unusually poor production of type I interferons (IFNs-α/β) and the aberrant and delayed adaptive immune responses, indicating
    Document: Porcine reproductive and respiratory syndrome (PRRS) remains one of the most economically significant diseases in the swine industry worldwide. The current vaccines are less satisfactory to confer protections from heterologous infections and long-term persistence, and the need for better vaccines are urgent. The immunological hallmarks in PRRSV-infected pigs include the unusually poor production of type I interferons (IFNs-α/β) and the aberrant and delayed adaptive immune responses, indicating that PRRSV has the ability to suppress both innate and adaptive immune responses in the host. Type I IFNs are the potent antiviral cytokines and recent studies reveal their pleiotropic functions in the priming of expansion and maturation of adaptive immunity. Thus, IFN antagonism-negative PRRSV is hypothesized to be attenuated and to build effective and broad- spectrum innate and adaptive immune responses in pigs. Such vaccines are promising alternatives to traditional vaccines for PRRSV.

    Search related documents:
    Co phrase search for related documents
    • action mechanism and acute phase: 1, 2, 3, 4
    • action mechanism and adaptive immune response: 1, 2, 3
    • action mechanism and adaptive immune system: 1
    • action mechanism and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • action mechanism and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • action mechanism and adaptive innate immunity: 1, 2, 3, 4, 5
    • action mechanism and adaptive response: 1, 2, 3
    • action mechanism and additional challenge: 1
    • action mechanism and additional study: 1
    • action mechanism and local lymph node: 1
    • action mechanism and long survival: 1
    • action mechanism and long term treatment: 1, 2
    • action mechanism and lymph node: 1, 2, 3
    • action mechanism and lymphoid tissue: 1, 2